Trial Details
WITHDRAWNBasic Information
| Clinical ID | c4540 |
|---|---|
| Identifier | NCT00354367 |
| Trial Title | Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Certolizumab pegol |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2007-01 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |